Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Randomized Controlled Trial
. 2011 Oct;15(5):427-31.
doi: 10.1016/j.jaapos.2011.06.004.

Infant Aphakia Treatment Study: effects of persistent fetal vasculature on outcome at 1 year of age

David G Morrison  1 , M Edward Wilson, Rupal H Trivedi, Scott R Lambert, Michael J Lynn; Infant Aphakia Treatment Study Group
Collaborators, Affiliations
Randomized Controlled Trial

Infant Aphakia Treatment Study: effects of persistent fetal vasculature on outcome at 1 year of age

David G Morrison et al. J AAPOS. 2011 Oct.

Abstract

Background: The Infant Aphakia Treatment Study is a randomized trial that compares the treatment of unilateral congenital cataract with primary intraocular lens (IOL) implantation versus aphakic contact lens (CLs). The purpose of this study was to compare the outcomes for infants with lens opacity associated with persistent fetal vasculature (PFV) to those without.

Methods: Retrospective subgroup analysis of grating visual acuity at 1 year of age and adverse events up to 1 year after surgery in eyes identified intraoperatively as having evidence of mild PFV from the IATS.

Results: Of 83 infants, 18 (22%: 11 CL, 7 IOL) had PFV. Median logMAR visual acuity was 0.88 for patients with PFV and 0.80 for patients without PFV (P = 0.46). One or more adverse events up to 1 year after surgery occurred in 12 infants (67%) with PFV and 30 infants (46%) without PFV (P = 0.18). The incidence of adverse events was significantly greater in patients with PFV compared with patients without PFV in the CL group (55% vs 20%, P = 0.049) but not in the IOL group (86% vs 71%, P = 0.65), possibly because all children receiving IOLs had greater rates of adverse events when compared with aphakic children (73% vs 29%, P < 0.001).

Conclusions: Aphakic infants with mild PFV treated with CL had a greater incidence of adverse events after lensectomy compared with children with other forms of unilateral congenital cataract; nevertheless, similar visual outcomes at 1 year after surgery were obtained.

PubMed Disclaimer

Figures

FIG 1
FIG 1
Grating visual acuity results at 1-year after surgery.
See this image and copyright information in PMC

Comment in

References

    1. Infant Aphakia Treatment Study Group. Lambert SR, Buckley EG, Drews-Botsch C, et al. The infant aphakia treatment study: Design and clinical measures at enrollment. Arch Ophthalmol. 2010;128:21–27. - PMC - PubMed
    1. Infant Aphakia Treatment Study Group. Lambert SR, Buckley EG, Drews-Botsch C, et al. A randomized clinical trial comparing contact lens with intraocular lens correction of monocular aphakia during infancy: Grating acuity and adverse events at age 1 year. Arch Ophthalmol. 2010;128:810–818. - PMC - PubMed
    1. Reese AB. Persistent hyperplastic primary vitreous. The Edward Jackson Memorial Lecture. Am J Ophthalmol. 1955;40:317–331. - PubMed
    1. Lloyd IC, Goss-Sampson M, Jeffrey BG, et al. Neonatal cataract: Aetiology, pathogenesis, and management. Eye. 1992;6:184–196. - PubMed
    1. Lambert SR, Drack AV. Infantile cataracts. Surv Ophthalmol. 1996;40:427–458. - PubMed

Publication types

MeSH terms